The data presented herein are consistent with the notion that elevated ApoB, even at extreme levels, does not drive atherosclerosis in a dose-dependent manner in this population of metabolically healthy individuals with carbohydrate restriction-induced elevations in LDL-C and ApoB. Here, APOB is linked to atherosclerosis.